FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Discount Store Generic Drugs Will Sell Well

[ Price : $8.95]

Consumers tell the Wall Street Journal Online/Harris Interactive Health-Care Poll they are likely to go to mega-stores to buy disc...

FDA/FTC Go After Bogus Diabetes Products

[ Price : $8.95]

FDA and FTC launch an enforcement initiative to stop deceptive Internet sales of bogus diabetes products.

Expanded Remicade Indication OK

[ Price : $8.95]

FDA approves expanding Remicades indication to include maintaining clinical remission and mucosal healing in patients with moderat...

PDUFA 4 Agreement Open for Public Comment: Jenkins

[ Price : $8.95]

CDER Office of New Drugs director John Jenkins tells RAPS that once a negotiated PDUFA 4 reauthorization agreement is reached it w...

FDA OKs MedMiras Rapid HIV Test

[ Price : $8.95]

FDA approves MedMiras Reveal G3 Rapid HIV-1 Antibody Test which can deliver results in less than three minutes.

OGD Wants Lidoderm Bioquivalence Study

[ Price : $8.95]

Endo disagrees with Office of Generic Drug recommendations for the kinds of studies needed to demonstrate bioequivalence to its Li...

Crawford Blatantly Violated Financial Principles: Fed

[ Price : $8.95]

The District of Columbia U.S. Attorney calls former commissioner Lester Crawfords financial disclosure and conflict of interest vi...

Device Complaints Least Important Quality Indicator?

[ Price : $8.95]

CDRH medical device quality systems expert Kimberly Trautman tells RAPS that complaints received by manufacturers may not be the b...

Guidance on Antiretrovirals for HIV

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance on fixed dose combinations, co-packaged drug products, and single-entity versions...

Pediatric Studies Out for 5 Products

[ Price : $8.95]

Federal Register Notice: FDA posts summaries of pediatric studies for Altace, Gemzar, Lescol, Sandostatin LAR, and Serevent.